StockNews.AI
HIMS
StockNews.AI
57 days

HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

1. Robbins Geller investigates Hims & Hers for potential securities law violations. 2. Concerns over misleading statements by top Hims executives are being examined. 3. Novo Nordisk ended collaboration with Hims due to illegal compounding concerns. 4. Hims stock price dropped over 34% following the Novo Nordisk announcement. 5. Robbins Geller is a leading law firm for investor securities fraud litigation.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The investigation and stock drop signal investor distrust. Similar past cases resulted in significant losses for involved companies.

How important is it?

The investigation into Hims could severely impact investor confidence and stock price. Serious legal issues often lead to long-term reputational damage.

Why Short Term?

Immediate market reactions can lead to further declines. Short-term impacts are usually sharper in fraud allegations.

Related Companies

NVDAPFECVSAMGN
, /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims & Hers Health, Inc. (NYSE: HIMS) focused on whether Hims & Hers and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Hims & Hers investigation or if you are a Hims & Hers investor who suffered a loss and would like to learn more, you can provide your information here: https://www.rgrdlaw.com/cases-hims-hers-health-inc-investigation-hims.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. THE COMPANY: Hims & Hers is a telehealth company that provides prescription medications, over-the-counter medications, and personal care products. THE REVELATION: On June 23, 2025, Novo Nordisk A/S announced that it "terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing." On this news, the price of Hims & Hers stock fell more than 34%. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: https://www.rgrdlaw.com/services-litigation-securities-fraud.html Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.  Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]  SOURCE Robbins Geller Rudman & Dowd LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News